Contrast dye test reveals hidden kidney damage in ICU survivors
NCT ID NCT02961478
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study uses a dye called iohexol to measure how well the kidneys are working in patients leaving the intensive care unit after acute kidney failure. The goal is to find out how many patients still have reduced kidney function even though their standard blood tests look normal. The results could help doctors better understand who needs long-term follow-up for kidney health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
iohexol (Omnipaque)
What this could lead to
If successful, this could help doctors better predict long-term kidney recovery in ICU survivors and guide follow-up care.
What could go wrong
This is a measurement study, not a treatment. It may not change outcomes directly, and iohexol clearance is not a standard test in all hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RENAL FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital
Le Mans, France
-
Hospital center
Chartres, France
-
Jean Perrin Center
Clermont-Ferrand, France
-
Saint-Louis Hospital APHP
Paris, France
-
University Hospital
Angers, France
-
University Hospital
Poitiers, France
-
University Hospital
Tours, France
-
University Hospital of Brest
Brest, France
-
University Hospital of NIce
Nice, France
-
University Hospital of Nantes
Nantes, France
-
Vendée Department Hospital Center
La Roche-sur-Yon, France